SIGLEC-5,SIGLEC-14 抗体
(2 references)-
- 抗原
- SIGLEC-5,SIGLEC-14
- 适用
- 人, Chimpanzee
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- 非结合性
-
应用范围
- Flow Cytometry (FACS), ELISA, Immunofluorescence (IF), Immunoprecipitation (IP)
- 交叉反应
- Chimpanzee
- 产品特性
- Purified IgG
- 纯化方法
- Purified
- 免疫原
- Siglec-5-Fc protein, consisting of the full-length extracellular region of human Siglec-5, fused with the Fc region of human IgG1.
- 克隆位点
- 1A5
- 亚型
- IgG1
-
anti-SIGLEC-5,SIGLEC-14 (Internal Region) antibody
适用: 人 ELISA, IHC (p), WB 宿主: 兔 Polyclonal unconjugated
anti-SIGLEC-5,SIGLEC-14 antibody (PE)适用: 人, Chimpanzee FACS 宿主: 小鼠 Monoclonal 1A5 PE
anti-SIGLEC-5,SIGLEC-14 (Internal Region) antibody适用: 人 ELISA, IHC (p), WB 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1.0 mg/mL
-
-
: "Loss of Siglec expression on T lymphocytes during human evolution." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 20, pp. 7765-70, (2006) (PubMed).
: "Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation." in: The Journal of biological chemistry, Vol. 280, Issue 20, pp. 19843-51, (2005) (PubMed).
-
: "Loss of Siglec expression on T lymphocytes during human evolution." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 20, pp. 7765-70, (2006) (PubMed).
-
-
